Protolimonoids from Melia toosendan

Journal of Natural Products

Volumn 72, Issue 5, 2009, Pages 917-920

  Yi, Shu Sang ^a,c   Chun, Yan Zhou ^a   Ai, Jun Lu ^a   Xiao, Jin Yin ^a   Zhi, Da Min ^b   Ren, Xiang Tan ^c  

^a Jiangsu Simcere Pharmaceutical R and D Co Ltd   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; MELIA TOOSENDAN EXTRACT; PLANT EXTRACT; PROTOLIMONOID DERIVATIVE; TOOSENDANIC ACID A; TOOSENDANIC ACID B; TOOSENDANONE A; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MEDICINAL PLANT; MELIA TOOSENDAN; MELIACEAE; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY DIFFRACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; HL-60 CELLS; HT29 CELLS; HUMANS; MELIA; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; TRITERPENES;

MELIA TOOSENDAN;

EID: 66449099762     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np800669c     Document Type: Article

References (15)

1. Akhila, A.; Rani, K. Progress in the Chemistry of Organic Natural Products; Springer-Verlag: Vienna, 1999; Vol.78, pp 47-149.
2. Zhang, B.; Wang, Z. F.; Tang, M. Z.; Shi, Y. L. Invest. New Drugs 2005, 23, 547-553.
3. Mohamad, K.; Martin, M. T.; Litaudon, M.; Gaspard, C.; Sévenet, T.; Päs, M. Phytochemistry 1999, 52, 1461-1468.
4. Luo, X. D.; Wu, S. H.; Ma, Y. B.; Wu, D. G. Fitoterapia 2000, 71, 668-672.
5. Grosvenor, S. N. J.; Mascoll, K.; McLean, S.; Reynolds, W. F.; Tinto, W. F. J. Nat. Prod. 2006, 69, 1315-1318.
6. Siddiqui, S.; Siddiqui, B. S.; Ghiasuddin; Faizi, S. Phytochemistry 1991, 30, 1615-1619.
7. Kumar, V.; Niyaz, N. M. M.; Wickramaratne, D. B. M.; Balasubramaniam, S. Phytochemistry 1991, 30, 1231-1233.
8. Itokawa, H.; Kishi, E.; Morita, H.; Takeya, K. Chem. Pharm. Bull. 1992, 40, 1053-1055.
9. Pettit, G. R.; Numata, A.; Iwamoto, C.; Morito, H.; Yamada, T.; Goswami, A.; Clewlow, P. J.; Cragg, G. M.; Schmidt, J. M. J. Nat. Prod. 2002, 65, 1886-1891.
10. Crystallographic data for toosendanone A (1) have been deposited at the Cambridge Crystallographic Data Centre as supplementary publication number CCDC-684135. Copies of the data can be obtained, free of charge, on application to the Director, 12 Union Road, Cambridge CB2 1EZ, UK (fax +44-(0) 1223-336033 or e-mail: deposit@ccdc.cam.ac.uk).
11. Lightner, D. A.; Gurst, J. E. Organic Conformational Analysis and Stereochemistry from Circular Dichroism Spectroscopy; John Wiley & Sons: New York, 2000; p 242.
12. Chiang, C. C.; Chang, F. C. Tetrahedron 1973, 29, 1911-1929.
13. Zhao, W. M.; Fan, C. Q.; Zhang, Z. Chin. Chem. Lett. 1999, 10, 289-290.
14. Akihisa, T.; Tabata, K.; Banno, N.; Tokuda, H.; Nishihara, R.; Nakamura, Y.; Kimura, Y.; Yasukawa, K.; Suzuki, T. Biol. Pharm. Bull. 2006, 29, 1976-1979.
15. Usubillaga, A.; Khouri, N.; Bahsas, A.; Andres, A.; Rojas, L. B. Rev. Latinoam. Quim. 2004, 32, 101-108.